Loading university
Michael H Gelb — Dr. Michael H Gelb's lab at the University of Washington focuses on improving newborn screening for genetic diseases using advanced biochemical and molecular techniques. Their research aims to develop innovative methods to analyze DNA variants and protein mutations that could influence disease outcomes. This work could significantly enhance how newborns are screened for treatable conditions, leading to better health strategies and reduced anxiety for families.
Christopher Dirk Keene — Dr. Christopher Dirk Keene's lab focuses on understanding the complex relationship between traumatic brain injuries and the progression of Alzheimer's disease and related dementias. The lab aims to establish a comprehensive resource that combines brain imaging, neuropathology, and extensive clinical data to improve diagnostics and therapeutic strategies for affected individuals. The research not only emphasizes scientific insights but also prioritizes diversity and inclusion within the research community.
John D Scott — Dr. John D. Scott's lab at the University of Washington studies how specific proteins can control the release of cortisol, the stress hormone, from our adrenal glands. They focus on a condition called Cushing's syndrome, which causes the body to produce too much cortisol, leading to serious health issues. The lab's goal is to understand the mutations in a protein called PKA that contribute to this syndrome and to develop more effective treatments using precision medicine.
Sara Mostafavi — Dr. Sara Mostafavi's lab at the University of Washington focuses on using advanced computational models to understand how genetic variations influence gene expression and contribute to complex diseases like autism spectrum disorder and schizophrenia. By integrating diverse genomic data, the lab works to develop tools that can predict functional outcomes from personal genomes, helping to uncover the biological processes behind these conditions and potentially leading to personalized therapeutic strategies.
Chun Yuan — Dr. Chun Yuan's lab at the University of Washington focuses on advancing techniques in MRI to better understand and classify ischemic strokes. By developing automated analysis tools, their research aims to provide clearer diagnostics for stroke patients, particularly those with unclear causes, allowing for more targeted treatment options. The lab integrates state-of-the-art imaging and machine learning methods to enhance stroke prevention strategies.
Ferric C Fang — Dr. Ferric C. Fang's lab at the University of Washington focuses on understanding enteric fever caused by Salmonella bacteria. The lab utilizes innovative models, including humanized mice, to study how Salmonella Typhi and Salmonella Paratyphi A evade the immune system and persist in the host. Their research aims to uncover new strategies for preventing and treating infections related to these pathogens.
Cecilia M Giachelli — Dr. Cecilia Giachelli's lab at the University of Washington is focused on understanding how and why calcium builds up in blood vessels and heart valves, a process known as vascular calcification. This condition can lead to serious heart issues, especially in older adults and those with diabetes or kidney disease. The lab investigates the biological processes and genetic factors involved in this calcification to identify potential treatments and biomarkers that can improve cardiovascular health and prevent complications.
Daniel T Chiu — Daniel T. Chiu's lab at the University of Washington focuses on developing innovative technologies to study gene expression in tissues and fetal health. They work on advanced imaging methods for analyzing tissues and biomarkers found in pregnant women, providing critical insights into conditions like neonatal abstinence syndrome. Their research combines chemistry and molecular biology techniques to enhance our understanding of complex biological systems.
James P Hughes — Dr. James P. Hughes leads a research lab focused on improving statistical methods for HIV/AIDS research. His work aims to enhance clinical trials and laboratory studies related to HIV, ultimately contributing to better prevention and treatment strategies. The lab's statistical innovations are also applicable to other communicable diseases, making it a significant contributor to public health efforts.